Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials

被引:16
|
作者
Scheuermann, Joshua S. [1 ]
Reddin, Janet S. [1 ]
Opanowski, Adam [2 ]
Kinahan, Paul E. [3 ]
Siegel, Barry A. [4 ,5 ]
Shankar, Lalitha K. [6 ]
Karp, Joel S. [1 ]
机构
[1] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
[2] Amer Coll Radiol Imaging Network, Philadelphia, PA USA
[3] Univ Washington, Dept Radiol, Seattle, WA 98195 USA
[4] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA
[5] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
[6] NCI, Canc Imaging Program, Rockville, MD USA
关键词
CQIE; PET qualification; quantitative imaging; STANDARDIZED UPTAKE VALUE; F-18-FDG PET/CT; MULTICENTER TRIALS; FDG-PET/CT; NETWORK; EXPERIENCE; BIOMARKER; VARIANCE; PROTOCOL; THERAPY;
D O I
10.2967/jnumed.116.186759
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The National Cancer Institute developed the Centers for Quantitative Imaging Excellence (CQIE) initiative in 2010 to prequalify imaging facilities at all of the National Cancer Institute-designated comprehensive and clinical cancer centers for oncology trials using advanced imaging techniques, including PET. Here we review the CQIE PET/CT scanner qualification process and results in detail. Methods: Over a period of approximately 5 y, sites were requested to submit a variety of phantoms, including uniform and American College of Radiology-approved phantoms, PET/CT images, and examples of clinical images. Submissions were divided into 3 distinct time periods: initial submission (T0) and 2 requalification submissions (T1 and T2). Images were analyzed using standardized procedures, and scanners received a pass or fail designation. Sites had the opportunity to submit new data for scanners that failed. Quantitative results were compared across scanners within a given time period and across time periods for a given scanner. Results: Data from 65 unique PET/CT scanners across 56 sites were submitted for CQIE T0 qualification; 64 scanners passed the qualification. Data from 44 (68%) of those 65 scanners were submitted for T2. From T0 to T2, the percentage of scanners passing the CQIE qualification on the first attempt rose from 38% for T1 to 67% for T2. The most common reasons for failure were SUV outside specifications, incomplete submission, and uniformity issues. Uniform phantom and American College of Radiology-approved phantom results between scanner manufacturers were similar. Conclusion: The results of the CQIE process showed that periodic requalification may decrease the frequency of deficient data submissions. The CQIE project also highlighted the concern within imaging facilities about the burden of maintaining different qualifications and accreditations. Finally, for quantitative imaging-based trials, further evaluation of the relationships between the level of the qualification (e.g., bias or precision) and the quality of the image data, accrual rates, and study power is needed.
引用
收藏
页码:1065 / 1071
页数:7
相关论文
共 50 条
  • [41] Management of Occult Primary Breast Cancer at a National Cancer Institute-Designated Comprehensive Cancer Center
    Fayanju, Oluwadamilola
    Jeffe, Donna
    Margenthaler, Julie
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 40 - 40
  • [42] Differences in Patients, Surgical Complexity, and Outcomes After Cancer Surgery at National Cancer Institute-designated Cancer Centers Compared to Other Hospitals
    Merkow, Ryan P.
    Bentrem, David J.
    Chung, Jeanette W.
    Paruch, Jennifer L.
    Ko, Clifford Y.
    Bilimoria, Karl Y.
    MEDICAL CARE, 2013, 51 (07) : 606 - 613
  • [43] Classical Hematology Referrals at an National Cancer Institute-Designated Cancer Center: Lessons Learned
    West, Chase V.
    Butler, Matthew J.
    Kaur, Supreet
    Bowhay-Carnes, Elizabeth
    Karnad, Anand B.
    JCO ONCOLOGY PRACTICE, 2024, 20 (01)
  • [44] The availability/accessibility gap of palliative care and supportive care services at 40 National Cancer Institute-designated cancer centers.
    Hutchins, Kathryn
    Hamlyn, Geoffrey
    Johnston, Abby
    Thomas, Rishonda
    Tian, James
    Kamal, Arif
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
  • [45] Masking Policies at National Cancer Institute-Designated Cancer Centers During Winter 2023 to 2024 COVID-19 Surge
    Hoerger, Michael
    Rivera, Dulce
    Mossman, Brenna
    Sherard, Birney
    Peyser, Tristen
    Alcorn, Taylor M.
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [46] Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs
    Dickens, David S.
    Roth, Michael E.
    Pollock, Brad H.
    Langevin, Anne-Marie
    JCO ONCOLOGY PRACTICE, 2020, 16 (10) : 677 - +
  • [47] Price variability of pembrolizumab across US National Cancer Institute-designated Cancer Centers (NCICCs) from 2016-2021.
    Hussaini, S. M. Qasim
    Johnson, Jordan
    Chino, Fumiko
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 48 - 48
  • [48] Accessibility and Barriers to Oncology Appointments at 40 National Cancer Institute-Designated Comprehensive Cancer Centers: Results of a Mystery Shopper Project
    Hamlyn, Geoffrey S.
    Hutchins, Kathryn E.
    Johnston, Abby L.
    Thomas, Rishonda T.
    Tian, James
    Kamal, Arif H.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (10) : E884 - +
  • [49] Special Convening and Listening Session on Health Equity and Community Outreach and Engagement at National Cancer Institute-Designated Comprehensive Cancer Centers
    Doykos, Patricia M.
    Chen, Moon S., Jr.
    Watson, Karriem
    Henderson, Vida
    Baskin, Monica L.
    Downer, Sarah
    Smith, Lauren A.
    Bhavaraju, Neeraja
    Dina, Samantha
    Lathan, Christopher S.
    HEALTH EQUITY, 2021, 5 (01) : 84 - 90
  • [50] Oncologists' perspectives on concurrent palliative care in a National Cancer Institute-designated comprehensive cancer center
    Bakitas, Marie
    Lyons, Kathleen Doyle
    Hegel, Mark T.
    Ahles, Tim
    PALLIATIVE & SUPPORTIVE CARE, 2013, 11 (05) : 415 - 423